[AEMD] Aethlon Medical, Inc.

Overview

Type of security: Stock

Sector: Capital Goods

Industry: Biotechnology: Laboratory Analytical Instruments

Market Capitalization: 55.25 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 4.24 Change: -0.16 (-3.64%)
Ext. hours: Change: 0 (0%)

chart AEMD

Refresh chart

Strongest Trends Summary For AEMD

AEMD is in the medium-term up 209% above S&P in 1 year. In the long-term up 157% above S&P in 2 years and down -73% below S&P in 7 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding7.62 M EPS-0.81 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 290.2% Sales Growth - Q/Q503.03% P/E
P/E To EPS Growth P/S72.5 P/BV89.83 Price/Cash Per Share
Price/Free Cash Flow ROA-492.18% ROE-1103.41% ROI
Current Ratio2.1 Quick Ratio Long Term Debt/Equity0.25 Debt Ratio0.93
Gross Margin Operating Margin-524.02% Net Profit Margin-892% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities4.65 M Cash From Investing Activities Cash From Operating Activities-5.05 M Gross Profit
Net Profit-890 K Operating Profit-1.14 M Total Assets1.38 M Total Current Assets1.2 M
Total Current Liabilities570 K Total Debt160 K Total Liabilities770 K Total Revenue200 K
Technical Data
High 52 week3.97 Low 52 week0.22 Last close3.97 Last change1370.37%
RSI98.18 Average true range0.33 Beta0.36 Volume17.67 K
Simple moving average 20 days791.13% Simple moving average 50 days1062.18% Simple moving average 200 days493.09%
Performance Data
Performance Week1370.37% Performance Month1370.37% Performance Quart1140.62% Performance Half459.16%
Performance Year242.24% Performance Year-to-date139.16% Volatility daily57.47% Volatility weekly128.5%
Volatility monthly263.34% Volatility yearly912.25% Relative Volume147.97% Average Volume164 K
New High New Low-2.53%

News

2019-11-15 05:04:49 | Here's Why We Worry About Aethlon Medical's NASDAQ:AEMD Cash Burn Situation

2019-11-01 16:15:00 | Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

2019-10-29 15:17:00 | Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on November 1, 2019

2019-10-28 07:00:00 | AEMD: IDE Approved. Hemopurifier U.S. Clinical Cancer Program On-Deck…

2019-10-14 15:55:00 | Aethlon Announces Reverse Stock Split

2019-10-07 08:31:00 | Aethlon Medical Announces FDA Approval Of IDE For Oncology Indications

2019-10-03 08:31:00 | Aethlon Medical Receives Extension from Nasdaq to Regain Compliance with Continued Listing Requirements

2019-10-01 05:57:47 | How Much Of Aethlon Medical, Inc. NASDAQ:AEMD Do Insiders Own?

2019-09-24 14:20:16 | Market Morning: Prorogation Ruled Rogue, High Demand for Fed Repo, New Breast Cancer Tests

2019-09-24 10:30:00 | Aethlon Announces Collaboration to Identify Exosomes Involved in Cancer Progression and Treatment Resistance

2019-09-16 08:31:00 | Aethlon Medical Receives National Cancer Institute Contract Award

2019-08-14 16:15:00 | Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

2019-08-07 13:36:00 | Aethlon Medical To Release First Quarter Financial Results and Host Conference Call on August 14, 2019

2019-07-08 10:20:00 | AEMD: SeaStar Collaboration Is Intriguing, More Evidence of Exosomes’ Role in Cancer Progression

2019-07-01 16:15:00 | Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

2019-07-01 14:30:00 | Aethlon Medical, Inc. to Host Earnings Call

2019-07-01 08:31:00 | Aethlon Medical, Inc. and SeaStar Medical, Inc. Announce Strategic Joint Cross-Licensing Agreement

2019-06-19 14:00:00 | Aethlon Medical To Release Fiscal Year End Financial Results and Host Conference Call on July 1, 2019

2019-05-13 08:00:00 | Aethlon Medical Announces Collaboration With Prostate On-Site Project POP, Host Of The Jerry Colangelo Sports Legend Golf Classic, To Engage With Participants For CTE Studies

2019-04-17 08:27:00 | Aethlon Medical Releases Shareholder Update

2019-04-05 12:31:40 | How Financially Strong Is Aethlon Medical, Inc. NASDAQ:AEMD?

2019-03-07 08:47:00 | Aethlon Medical, Inc. Announces Appointment of Lisa M. Boswell as Director, Quality Systems and Regulatory Affairs

2019-02-13 15:45:00 | AEMD: Eventual FDA Cancer Indication Is A Realistic Outcome

2019-02-11 16:15:00 | Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

2019-02-11 14:30:00 | Aethlon Medical, Inc. to Host Earnings Call

2019-02-04 14:49:00 | Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on February 11, 2019

2019-01-18 07:35:00 | Market Trends Toward New Normal in Roper Technologies, The AES, D.R. Horton, Forrester Research, Aethlon Medical, and CyberOptics — Emerging Consolidated Expectations, Analyst Ratings

2018-12-13 08:29:00 | Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer

2018-11-28 06:50:00 | Today’s Research Reports on Stocks to Watch: Arsanis and Aethlon Medical

2018-11-27 13:30:00 | AEMD: Breakthrough Device Designation Granted for Cancer Therapy. Could Be Game-Changer for AEMD

2018-11-27 10:10:00 | The Reason Healthcare Stocks Are Being Called Home By Investors

2018-11-27 07:21:00 | Aethlon Medical's Cancer Therapy Receives _Breakthrough Device_ Designation from the U.S. Food and Drug Administration

2018-11-12 09:45:00 | AEMD: Pivot Towards Cancer Makes Sense. FDA Filing For Breakthrough Device in Cancer

2018-11-12 08:15:00 | Research Report Identifies Prudential Financial, Second Sight Medical Products, Acushnet, Repligen, Scorpio Tankers, and Aethlon Medical with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-11-06 16:15:00 | Aethlon Medical Announces Second Quarter Fiscal Year 2019 Results

2018-11-01 08:30:00 | Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on November 6, 2018

2018-10-29 11:59:00 | Aethlon Medical to Present at the NYC Oncology Conference

2018-10-18 09:25:00 | Investor Expectations to Drive Momentum within Aethlon Medical, Jaguar Animal Health, Advaxis, Forestar Group, Platform Specialty Products, and AVEO Pharmaceuticals — Discovering Underlying Factors of Influence

2018-10-16 08:15:00 | Aethlon Medical to Present at the 2018 BIO Investor Forum

2018-10-09 13:06:41 | How Financially Strong Is Aethlon Medical Inc NASDAQ:AEMD?

2018-09-18 08:46:00 | Aethlon Medical Receives National Cancer Institute Award

2018-08-28 09:15:00 | AEMD: Compassionate Use, Real-World Data, Awaiting FDA Final Guidance

2018-08-27 08:00:00 | Research Report Identifies Ball, Aethlon Medical, NeoGenomics, Del Taco Restaurants, Arconic, and Agilysys with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-08-08 16:15:00 | Aethlon Medical Announces First Quarter Fiscal Year 2019 Results

2018-08-08 14:30:00 | Aethlon Medical, Inc. to Host Earnings Call

2018-08-02 08:15:00 | Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018

2018-06-27 09:15:53 | Loss-Making Aethlon Medical Inc NASDAQ:AEMD Expected To Breakeven

2018-06-25 09:15:00 | Guy Cipriani Joins Aethlon Medical's Board of Directors

2018-06-21 07:55:00 | New Research: Key Drivers of Growth for Nicolet Bankshares, Vitamin Shoppe, Aethlon Medical, Barrett Business Services, Veracyte, and TPG Specialty Lending — Factors of Influence, Major Initiatives and Sustained Production

2018-06-13 09:30:00 | AEMD: AEMD In Active Discussions With FDA Regarding Hemopurifier Pathway